Clinical study of pronase for improving visibility and safety in colonoscopy
BACKGROUND: This is a multicenter, randomized, double-blind, placebo-controlled interventional clinical study to evaluate the efficacy and safety of pronase in improving visibility in colonoscopy and to evaluate whether pronase can increase the detection rate of intestinal lesions and the colonoscopist's satisfaction. METHODS: From June 2023 to December 2023, a total of 1942 patients undergoing air insufflation colonoscopy in 10 hospitals (The First Medical Center, Chinese PLA General Hospital, et al) were selected as the study subjects. They were randomly divided into two groups: (1) the experimental group (n = 969) was given pronase for flushing in colonoscopy; and (2) the control group (n = 973) was given physiological saline for flushing in colonoscopy. The improvement of the visibility at the target site (region of interest) in colonoscopy was evaluated in two groups to verify the efficacy of pronase in improving visibility in colonoscopy. The safety of pronase for flushing in colonoscopy was evaluated by comparing the incidence of adverse events between the two groups. RESULTS: After the use of pronase in colonoscopy, the patient's vital signs remained stable, without serious adverse reactions. The improvement rate of visibility in the pronase group was significantly higher than that in the physiological saline group (97.21% [942/969] vs. 86.74% [844/973], P <0.0001), and the subgroup analysis (Boston Bowel Preparation Scale ≥6 points) showed similar results to the overall ones. The physician's satisfaction score in the pronase group was significantly increased. There was no significant statistical difference in the detection rates of adenoma, colorectal cancer, minimal lesions, non-polypoid colorectal lesions, polyps, and precancerous lesions between the two groups. CONCLUSIONS: Pronase can improve the visibility in colonoscopy and help physicians observe the lesions better. Pronase demonstrates good safety in colonoscopy, with no significant difference compared to physiological saline.
Authors
- Danian Ji (ORCID: https://orcid.org/0000-0003-3201-9163)
- Enqiang Linghu (ORCID: https://orcid.org/0000-0003-4506-7877)
- Weijian Lun (ORCID: https://orcid.org/0000-0002-5594-9075)
- Tanzhou Chen (ORCID: https://orcid.org/0000-0002-8307-2389)
- Guodong Li (ORCID: https://orcid.org/0009-0000-1334-3369)
- Yuehua Chen (ORCID: https://orcid.org/0009-0006-1343-7449)
- B Tuo
- Bo Zhang
- Wen Wang
- Peng Li
- Xing Chen
Institutions
- Sun Yat-sen University (CN)
- Shanxi Medical University (CN)
- Zunyi Medical University (CN)
- Capital Medical University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Chinese PLA General Hospital (CN)
- Third Affiliated Hospital of Southern Medical University (CN)
- Sixth Affiliated Hospital of Sun Yat-sen University (CN)
- Huadong Hospital (CN)
- 174th hospital of the People's Liberation Army (CN)
- Shandong Provincial Hospital (CN)
- First Hospital of Shanxi Medical University (CN)
- Beijing Friendship Hospital (CN)
- First Affiliated Hospital of Jinan University (CN)
- Shandong First Medical University (CN)
- Affiliated Hospital of Zunyi Medical College (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2026-06-09
- DOI
- https://doi.org/10.1097/cm9.0000000000004114
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00